Results 251 to 260 of about 682,316 (295)

Pulmonary effects of marijuana inhalation

Expert Review of Respiratory Medicine, 2011
Marijuana is the most commonly used illicit drug around the world. It is most often consumed through smoking, placing the respiratory system in direct contact with the toxic constituents of the drug, which are similar to those of tobacco cigarettes. However, accurate study of the adverse effects of marijuana is difficult to perform, owing to marijuana ...
Megan L, Howden, Matthew T, Naughton
openaire   +2 more sources

Milk antibodies in pulmonary inhalation

Journal of Paediatrics and Child Health, 1983
ABSTRACT. To determine the association between inhalation and increased circulating milk antibodies, the presence of milk precipitins and haemagglutinating titres of antibody to casein and lactalbumin were determined in a series of 100 children studied by radionuclide ‘milk scan’and/or barium swallow for possible milk inhalation.
A S, Kemp, P, McVeagh, E, Lo, R, Howman-Giles   +3 more
openaire   +2 more sources

Pulmonary Delivery of Inhalable Nanoparticles: Dry Powder Inhalers

Therapeutic Delivery, 2011
Pulmonary administration of inhalable nanoparticles (NPs) is an emerging area of interest. Dry powder inhalers may offer particular advantages for pulmonary administration of NPs. This article reviews research performed on the formulation of inhalable NPs as dry powder to achieve deep-lung deposition and enhance NP redispersibility.
M H D Kamal, Al-Hallak, Muhammad Khan, Sarfraz, Shirzad, Azarmi, Wilson H, Roa, Warren H, Finlay, Raimar, Löbenberg   +5 more
openaire   +2 more sources

Pulmonary Distribution of an Inhaled Radioaerosol in Obstructive Pulmonary Disease

Radiology, 1976
Pulmonary distribution of an inhaled radioaerosol was analyzed in 20 cases of chronic obstructive pulmonary disease (COPD) and 8 of other OPD. Nonciliary/ciliary partition of the distribution correlated with the severity of airway obstruction and approximated 3:1 in mild and 1:3 in very severe obstruction.
M S, Lin, D A, Goodwin
openaire   +2 more sources

Inhalational Drug Delivery in Pulmonary Aspergillosis

Critical Reviews™ in Therapeutic Drug Carrier Systems, 2019
Pulmonary infections have long represented one of the major threats to humans. These vary from acute to chronic conditions, depending upon the underlying disease of the airways. Pulmonary aspergillosis (PMAP) has raised vital concerns in the immunocompromised patients.
Ranjot, Kaur, Ripandeep, Kaur, Charan, Singh, Shahdeep, Kaur, Amit K, Goyal, Kamalinder K, Singh, Bhupinder, Singh   +6 more
openaire   +2 more sources

Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis

New England Journal of Medicine
Preclinical data indicate that inhaled treprostinil may be useful for the treatment of idiopathic pulmonary fibrosis (IPF) through an antifibrotic mechanism, a premise that is supported by clinical observation.In this phase 3, double-blind trial, we randomly assigned patients with IPF to receive inhaled treprostinil or placebo (12 breaths four times ...
Steven D. Nathan, Peter Smith, Chunqin Deng, Maria De Salvo, Wim Wuyts, Juana Pavie-Gallegos, Jin Woo Song, Mordechai R. Kramer, Christopher S. King, John A. Mackintosh, Daniel Chambers, Georgina Viviana Miranda, Natalie Breytenbach, Leigh Peterson, Heidi Bell, Kevin R. Flaherty, Juergen Behr, Vincent Cottin   +17 more
openaire   +3 more sources

Inhaled prostacyclin in the treatment of pulmonary hypertension

European Journal of Pediatrics, 1999
Pulmonary hypertension can occur primarily with an unknown aetiology or secondary in association with cardiac or pulmonary disorders such as congenital diaphragmatic hernia, idiopathic respiratory distress syndrome, acute respiratory distress syndrome (ARDS), congenital heart disease with malformation of the pulmonary blood vessels, chronic obstructive
M, Max, R, Rossaint
openaire   +2 more sources

Inhalation of Ethyl Alcohol for Pulmonary Edema

New England Journal of Medicine, 1951
TREATMENT of experimental pulmonary edema with ethyl alcohol as an antifoaming agent has been described by Luisada.1 However, no clinical experience with this agent has as yet appeared in the liter...
A, GOOTNICK, H I, LIPSON, J, TURBIN
openaire   +2 more sources

Pulmonary toxicity of inhaled and intravenous talc

Toxicology Letters, 1990
Talc (magnesium silicate) is a widely used, generally considered benign substance. It is principally used as an inert filler material in drug tablets or as a drying ingredient in baby powders. However, in both cases inappropriate use can lead to severe pulmonary toxicological responses.
openaire   +2 more sources

INHALATION PULMONARY SCINTIPHOTOGRAPHY USING PERTECHNETATE

American Journal of Roentgenology, 1971
Inhalation lung scintiphotos of good quality with a minimum of bronchial deposition have been obtained using a simple, inexpensive nebulizing system and technetium in the pertechnetate form.The method described is a rapid means of obtaining useful information regarding airway patency with no radiopharmaceutical preparation.Pertechnetate is a suitable ...
D J, Cook, H, Lander
openaire   +2 more sources